Health

FDA Approves Merck’s Welireg (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)

DailyTrendDailyTrend
May 15, 2025 - 11:00
 0  0
FDA Approves Merck’s Welireg (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)
RAHWAY, N.J.--(BUSINESS WIRE) May 14, 2025 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved Welireg (belzutifan), Merck’s oral...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

FDA Approves Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the Treatment of Fibromyalgia

FDA Approves Tonmya (cyclobenzaprine hydrochloride subl...

DailyTrend Aug 16, 2025  0  0

A New Way to Reduce Children’s Deaths: Cash

A New Way to Reduce Children’s Deaths: Cash

DailyTrend Aug 18, 2025  0  0

Was Head-Binding an Ancient Way to Get Ahead?

DailyTrend Aug 22, 2025  0  0

Wegovy Granted Accelerated Approval in the US for the Treatment of MASH

Wegovy Granted Accelerated Approval in the US for the T...

DailyTrend Aug 18, 2025  0  0

Cases of Mosquito-Borne Chikungunya Virus Are Surging Globally: What to Know

Cases of Mosquito-Borne Chikungunya Virus Are Surging G...

DailyTrend Aug 19, 2025  0  0

Congo Has Astronomical Rates of Sexual Violence. Now Vi...

DailyTrend Aug 22, 2025  0  0